Solu
Founded 2023 · 9 employees on LinkedIn · 3 known investors
Solu provides a cloud-based genomic surveillance platform that analyzes microbial genomes in real-time without requiring coding or configuration. The platform serves public health institutions, research labs, and medical centers performing pathogen sequencing, outbreak detection, and antimicrobial resistance monitoring.
Investors · 3
Funding
SEC filings, press & company announcements- Undisclosed amountSeries AApr 2025Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Solu do?
- Solu provides a cloud-based genomic surveillance platform that analyzes microbial genomes in real-time without requiring coding or configuration. The platform serves public health institutions, research labs, and medical centers performing pathogen sequencing, outbreak detection, and antimicrobial resistance monitoring.
- Who are Solu's investors?
- Solu's investors include Lifeline Ventures, Wave Ventures, Pappas Capital.